HNSCC
Clinical trials for HNSCC explained in plain language.
Never miss a new study
Get alerted when new HNSCC trials appear
Sign up with your email to follow new studies for HNSCC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo tested in battle against tough head & neck cancers
Disease control TerminatedThis study tested whether adding an experimental drug called danvatirsen to a standard immunotherapy (pembrolizumab) worked better for people with advanced head and neck cancer that had spread or come back. About 69 participants were randomly assigned to receive either the two-dr…
Matched conditions: HNSCC
Phase: PHASE2 • Sponsor: Flamingo Therapeutics NV • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Short drug course aims to shrink tumors before cancer surgery
Disease control TerminatedThis study tested if giving the drug abemaciclib for 10-21 days before surgery could shrink tumors in patients with HPV-negative head and neck cancer. The goal was to see if the drug reduced tumor size and changed the immune environment around the cancer. The trial was small and …
Matched conditions: HNSCC
Phase: PHASE2 • Sponsor: University of Arizona • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC